EU approves 5th COVID-19 vaccine for bloc, one by Novavax

admin

Administrator
Jun 17, 2007
66,216
0
36
49
Canada
THE HAGUE, Netherlands (AP) — The European Union’s drugs regulator gave the green light Monday to a fifth COVID-19 vaccine for use in the 27-nation bloc, granting conditional marketing authorization to the two-dose vaccine made by U.S. biotech company Novavax. The European Medicines Agency decision to grant conditional marketing authorization for the vaccine for people aged 18 and over, which must be confirmed by the EU’s executive commission, comes as many European nations are battling surges i
 
Back
Top